It is a pharma private limited company based in Mumbai, Maharashtra, India, established in 1985.
1985 | Mumbai, Maharashtra, India | Converted to LLPMediorals Laboratories Private Limited, a converted to llp private limited company, was established on 08 October 1985 in Mumbai, Maharashtra, India. Engaging in drug formulation & development within the pharma sector, it holds CIN: U24110MH1985PTC037675. Registered under ROC Roc Mumbai. it is unlisted. It has an authorized capital of ₹2.54 Cr and a paid-up capital of ₹2.54 Cr.
Past directors included Rajendra Murari Apandkar, Hemant Satwikrao Lokhande, Hemant Deshpande. It holds no open charges and ₹5.43 Cr settled loans. Its latest AGM occurred on 30 September 2016, with the balance sheet filed on 31 March 2016. It is based at 12 Gunbow Streetfort, Mumbai, Maharashtra, 400001.
U24110MH1985PTC037675
037675
08 October 1985
₹2.54 Cr
₹2.54 Cr
Roc Mumbai
Unlisted
Converted to LLP
Explore comprehensive insights into Mediorals Laboratories Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 14 Oct 2009 | Past |
| Pramod Abcsdd | Director | 11 Feb 2017 | Past |
| Pramod Abcsdd | Additional Director | 30 Sep 2009 | Past |
| Pramod Abcsdd | Director | 11 Feb 2017 | Past |
| Pramod Abcsdd | Director | 11 Feb 2017 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Mediorals Laboratories Private Limited, for the financial year ended 2016, experienced significant growth in revenue, with a 1475.52% increase. The company also saw a substantial improvement in profitability, with a 18513.09% increase in profit. The company's net worth Soared by an impressive increase of 120.59%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2016, Mediorals Laboratories had a promoter holding of 100.00%. The company had 2 Subsidiaries. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹0
₹54,300,000.00
| Date | Lender | Amount | Status |
|---|---|---|---|
| 17 May 2001 | Bnp Paribas | ₹1.00 Cr | Satisfied |
| 17 Apr 2000 | Banque National De Paris | ₹1.00 Cr | Satisfied |
| 29 Aug 1998 | The Hongkong And Shanghai Banking Corporation Limited | ₹3.43 Cr | Satisfied |
Explore comprehensive loan charge details -
Unlock and access historical data on people associated with Mediorals Laboratories, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Mediorals Laboratories, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Mediorals Laboratories's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
The activity Mediorals Laboratories Private Limited last Annual general meeting of members was held on 30 Sep 2016 as per latest MCA records. was completed.
The activity Mediorals Laboratories Private Limited has filed its annual Financial statements for the year ended 31 Mar 2016 with Roc Mumbai. was completed.
Progress on A charge registered on 17 Apr 2000 via Charge ID 90166860 with Banque National De Paris was fully satisfied on 15 Feb 2016. was documented.
The activity A charge registered on 17 May 2001 via Charge ID 90166714 with Bnp Paribas was fully satisfied on 26 Oct 2015. was completed.
A charge registered on 29 Aug 1998 via Charge ID 90163759 with The Hongkong And Shanghai Banking Corporation Limited was fully satisfied on 09 Mar 2015. was recorded as a recent event.
Progress on A charge with Bnp Paribas amounted to Rs. 1.00 Cr with Charge ID 90166714 was registered on 17 May 2001. was documented.
The CIN of Mediorals Laboratories Private Limited is U24110MH1985PTC037675.
Mediorals Laboratories Private Limited is headquartered at 12 Gunbow Streetfort, Mumbai, Maharashtra, 400001.
Mediorals Laboratories Private Limited was incorporated on 08 October 1985.
The primary industry of Mediorals Laboratories Private Limited is Pharma.
Mediorals Laboratories Private Limited is unlisted.
The authorized capital of Mediorals Laboratories Private Limited is ₹2.54 Cr, and the paid-up capital is ₹2.54 Cr.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX